Research Article

Related GMR Articles

03/20/2015
Breast cancer; Circulating tumor cells; Herceptin

The objective of this study was to determine the changes in peripheral blood circulating tumor cells in HER2-positive early breast cancer before and after Herceptin therapy, and to explore the effects of the HER2 gene and Herceptin on circulating tumor cells. CK19 mRNA expression in peripheral blood was evaluated by qRT-PCR as an index of circulating tumor cells in 15 cases of HER-2- ... more

J.L. Zhang; Q. Yao; J.H. Chen; Y. Wang; H. Wang; Q. Fan; R. Ling; J. Yi; L. Wang
12/22/2015
AGER; Breast cancer; Lung cancer; Meta-analysis; Polymorphisms

We evaluated the associations between three common polymorphisms in the AGER gene and the risks of breast (BC) and lung (LC) cancer using meta-analysis. A systematic electronic search of the literature was conducted to identify all potential correlation studies in Embase, Web of Science, Cochrane Library, CINAHL, PubMed, CISCOM, China BioMedicine (CBM), and China National ... more

N.C. Yin; X.P. Lang; X.D. Wang; W. Liu
12/02/2015
8-Oxoguanine DNA glycosylase rs1052133; Base excision repair; Lung cancer; poly(ADP-ribose) polymerase 1 rs1136410; Single nucleotide polymorphisms; X-ray repair cross-complementing group 1 rs25487

Base excision repair (BER) plays an important role in maintaining genome integrity and anti-cancer drug resistance. Single nu­cleotide polymorphisms (SNPs) in BER genes were detected in 500 lung cancer patients and 500 cancer-free controls. A logistic regression model was applied to analyze the relationship between lung cancer susceptibility and BER SNPs coupled with a wide range of ... more

X. Wang; K.W. Ma; Y.G. Zhao; G.J. Wang; W. Li
11/19/2015
Doxorubicin; Lung cancer; Meloxicam; MRP; Xenograft

It has been suggested that selected COX inhibitors can overcome multidrug resistance through the inhibition of ATP‑binding cassette-transporter proteins thereby enhancing the inhibitory effect of doxorubicin on human tumor growth and promoting the actions of cytostatics. However, their effect on lung cancer and the molecular mechanisms involved in the overcoming of multidrug resistance ... more

S.F. Chen; Z.Y. Zhang; J.L. Zhang
04/07/2016
A1298C; C677T; Lung cancer; Meta-analysis; MTHFR; Polymorphisms

Results from previous studies on the association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms C677T and A1298C and lung cancer have been conflicting. The aim of this meta-analysis was to clarify the effect of MTHFR polymorphisms on the risk of lung cancer. An electronic search of PubMed, EMBASE, the Cochrane library, and the China Knowledge Resource ... more

Y. Yang; L.J. Yang; M.Z. Deng; Y.Y. Luo; S. Wu; L. Xiong; D. Wang; Y. Liu; H. Liu; Y. Yang; L.J. Yang; M.Z. Deng; Y.Y. Luo; S. Wu; L. Xiong; D. Wang; Y. Liu; H. Liu; Y. Yang; L.J. Yang; M.Z. Deng; Y.Y. Luo; S. Wu; L. Xiong; D. Wang; Y. Liu; H. Liu
10/17/2016
Cancer cell proliferation; Lung cancer; miR-129b; Non-small cell lung carcinoma

Lung cancer is one of the most prevalent malignant tumors, and is one of the primary causes of cancer-associated deaths. In 2002, an estimated 1.18 million lung cancer-associated deaths were recorded, accounting for 18% of cancer-related deaths and 2% of total mortality. Despite the great progress that has been made in lung cancer therapies, the mechanisms ... more

L. Zheng; Y.X. Qi; S. Liu; M.L. Shi; W.P. Yang
11/03/2016
Correlation analysis; CYP1A1, GSTP1, ERCC2, XRCC1, XRCC3; Gene polymorphism; Lung cancer

Lung cancer is a common malignant tumor that is characterized by high morbidity and poor prognosis. Studies suggest that an individual’s genetic background affects the risk of developing lung cancer. Therefore, we investigated the relationship between gene polymorphisms and susceptibility to lung cancer. We recruited 308 primary lung ... more

H.X. Liu; J. Li; B.G. Ye; H.X. Liu; J. Li; B.G. Ye
11/03/2016
Diagnosis; Lung cancer; Lung cancer screen; Serum tumor markers

Early detection and treatment is critically important for lung cancer patients. Inflammatory mediators such as IL-6, IL-10, and MCP-1 participate in lung cancer regulation. CEA, CA125, and ProGRP are commonly used serum tumor markers for lung cancer. In this study, we assessed the sensitivity and specificity of CEA, CA125, and ProGRP when used in combination with ... more

Y.W. Pan; Z.G. Zhou; M. Wang; J.Q. Dong; K.P. Du; S. Li; Y.L. Liu; P.J. Lv; J.B. Gao; Y.W. Pan; Z.G. Zhou; M. Wang; J.Q. Dong; K.P. Du; S. Li; Y.L. Liu; P.J. Lv; J.B. Gao
08/28/2015
Concurrent chemoradiotherapy; Cytokine-induced killer cells; Dendritic cells; Non-small cell lung cancer

To compare the efficacy of dendritic and cytokine-induced killer cells (DC-CIK) therapy combined with concurrent radiochemotherapy on stage IIIB non-small cell lung cancer. Sixty-three patients with stage IIIB non-small cell lung cancer were randomly divided into the study and control groups. The study group, comprising 30 patients, was treated with DC-CIK combined with docetaxel- ... more

X.P. Zhu; Y.H. Xu; J. Zhou; X.F. Pan
08/21/2015
Microwave ablation; Non-small cell lung cancer; Vascular endothelial growth factor

We aimed to analyze the changes of serum vascular endothelial growth factor (VEGF) before and after microwave ablation (MWA) in patients with stage IIIB-IV non-small cell lung cancer (NSCLC), and to observe the effects of MWA combined with chemotherapy on short-term therapeutic efficacy and long-term survival. Concentrations of serum VEGF in 20 healthy subjects were considered as controls ... more

Y.H. Sun; P.Y. Song; Y. Guo; M. Pang; W.N. He; W.H. Zhang; L.J. Sheng

Pages